BBR Partners LLC Sells 193 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

BBR Partners LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 27.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 500 shares of the healthcare conglomerate’s stock after selling 193 shares during the period. BBR Partners LLC’s holdings in UnitedHealth Group were worth $292,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $27,000. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter worth $31,000. Global Wealth Strategies & Associates grew its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC lifted its position in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

NYSE UNH opened at $608.38 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market capitalization of $559.88 billion, a PE ratio of 39.63, a PEG ratio of 1.78 and a beta of 0.58. The business’s 50-day moving average is $584.09 and its 200 day moving average is $555.02.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the company earned $6.56 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is 54.72%.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Barclays lifted their target price on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Stephens cut their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.